Drug development for childhood cancers.

Reaman GH, Pearson ADJ

DOI: 10.1016/s2352-4642(26)00265-8
Published: 2026 Dec
Container: The Lancet. Child & adolescent health
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-26-00265-8,
  title = {Drug development for childhood cancers.},
  author = {Reaman GH and Pearson ADJ},
  year = {2026},
  journal = {The Lancet. Child \& adolescent health},
  doi = {10.1016/s2352-4642(26)00265-8},
  url = {https://doi.org/10.1016/s2352-4642(26)00265-8}
}

RIS

TY  - JOUR
TI  - Drug development for childhood cancers.
AU  - Reaman GH
AU  - Pearson ADJ
PY  - 2026
JO  - The Lancet. Child & adolescent health
DO  - 10.1016/s2352-4642(26)00265-8
UR  - https://doi.org/10.1016/s2352-4642(26)00265-8
ER  -

APA

GH, R., & ADJ, P. (2026). Drug development for childhood cancers.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(26)00265-8

Source records

pubmed · retrieved 2026-11-10T13:57:38.188Z